Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Plos One|October 1, 2019
Inclusion of enclosed hydration effects in the binding free energy estimation of dopamine D3 receptor complexesRajat Kumar Pal, Satishkumar Gadhiya, Steven Ramsey, et al.ACS Medicinal Chemistry Letters|October 23, 2018
New Dopamine D3-Selective Receptor Ligands Containing a 6-Methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol MotifSatishkumar Gadhiya, Pierpaolo Cordone, Rajat K Pal, et al.Bioorganic & Medicinal Chemistry|April 2, 2016
Tetrahydroprotoberberine alkaloids with dopamine and σ receptor affinitySatishkumar Gadhiya, Sudharshan Madapa, Thomas Kurtzman, et al.Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ringWayne W Harding, Matthew Schmidt, Kevin Tidgewell, et al.Journal of Medicinal Chemistry|July 22, 2005
Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligandsWayne W Harding, Kevin Tidgewell, Nathan Byrd, et al.Journal of Natural Products|January 31, 2006
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin AWayne W Harding, Matthew Schmidt, Kevin Tidgewell, et al.Synapse (New York, N.Y.)|September 3, 2005
Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primatesMatthew D Schmidt, Mark S Schmidt, Eduardo R Butelman, et al.Organic Letters|July 1, 2005
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorumWayne W Harding, Kevin Tidgewell, Matthew Schmidt, et al.Journal of Natural Products|June 24, 2006
Synthesis of salvinorin A analogues as opioid receptor probesKevin Tidgewell, Wayne W Harding, Anthony Lozama, et al.Plos Computational Biology|January 18, 2023
End-to-end sequence-structure-function meta-learning predicts genome-wide chemical-protein interactions for dark proteinsTian Cai, Li Xie, Shuo Zhang, et al.Pageof 6